Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Guidance from the PLANET Study.

Chronic kidney disease Diabetes mellitus Hypertension Insomnia Lower urinary tract symptoms Nocturia Obstructive sleep apnoea

Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
01 2022
Historique:
received: 23 12 2021
accepted: 07 01 2022
pubmed: 2 2 2022
medline: 14 4 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Patients with nocturia are commonly referred to urology clinics, including many for whom a nonurological medical condition is responsible for their symptoms. The PLanning Appropriate Nocturia Evaluation and Treatment (PLANET) study was established to develop practical approaches to equip healthcare practitioners to deal with the diverse causes of nocturia, based on systematic reviews and expert consensus. Initial assessment and therapy need to consider the possibility of one or more medical conditions falling into the "SCREeN" areas of Sleep medicine (insomnia, periodic limb movements of sleep, parasomnias, and obstructive sleep apnoea), Cardiovascular (hypertension and congestive heart failure), Renal (chronic kidney disease), Endocrine (diabetes mellitus, thyroid disease, pregnancy/menopause, and diabetes insipidus), and Neurology. Medical and medication causes of xerostomia should also be considered. Some key indicators for these conditions can be identified in urology clinics, working in partnership with the primary care provider. Therapy of the medical condition in some circumstances lessens the severity of nocturia. However, in many cases there is a conflict between the two, in which case the medical condition generally takes priority on safety grounds. It is important to provide patients with a realistic expectation of therapy and awareness of limitations of current therapeutic options for nocturia. PATIENT SUMMARY: Nocturia is the symptom of waking at night to pass urine. Commonly, this problem is referred to urology clinics. However, in some cases, the patient does not have a urological condition but actually a condition from a different speciality of medicine. This article describes how best the urologist and the primary care doctor can work together to assess the situation and make sensible and safe treatment suggestions. Unfortunately, there is sometimes no safe or effective treatment choice for nocturia, and treatment needs to focus instead on supportive management of symptoms.

Identifiants

pubmed: 35101453
pii: S2405-4569(22)00007-4
doi: 10.1016/j.euf.2022.01.007
pii:
doi:

Types de publication

Practice Guideline Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-97

Subventions

Organisme : Department of Health
ID : PB-PG-1217-20034
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Matthew Smith (M)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Shoba Dawson (S)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Robert C Andrews (RC)

Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.

Sofia H Eriksson (SH)

Department of Clinical and Experiential Epilepsy, UCL Institute of Neurology, University College London, London, UK.

Hugh Selsick (H)

Insomnia and Behavioural Sleep Medicine, University College London Hospitals, London, UK.

Andrew Skyrme-Jones (A)

Cardiology Department, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Udaya Udayaraj (U)

Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, UK; Oxford Kidney Unit, Churchill Hospital, Oxford, UK.

Jonathan Rees (J)

Tyntesfield Medical Group, North Somerset, UK.

Edward Strong (E)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Emily J Henderson (EJ)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Older People's Unit, Royal United Hospital NHS Foundation Trust, Bath, UK.

Marcus J Drake (MJ)

Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Electronic address: marcus.drake@bui.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH